首页 | 本学科首页   官方微博 | 高级检索  
检索        

TP方案与NP方案诱导化疗晚期非小细胞肺癌的疗效观察
引用本文:孔轶.TP方案与NP方案诱导化疗晚期非小细胞肺癌的疗效观察[J].临床肺科杂志,2013,18(2):222-224.
作者姓名:孔轶
作者单位:湖南省肿瘤医院肝胆胰内科
摘    要:目的探讨TP方案和NP方案诱导化疗局部晚期NSCLC的疗效优势。方法收集我院2008年1月至2010年1月接受化疗的晚期非小细胞肺癌患者(其中鳞癌26例,腺癌44例,大细胞肺癌32例)102例,随机分为TP方案化疗组(A组,51例)和NP方案化疗组(B组,51例)。比较两组不同化疗方案治疗局部晚期NSCLC的近期疗效、Karnofsky评分、毒副反应和随访1、2年的生存情况。结果 A、B两组的总有效率分别为54.9%和43.1%,生活质量改善率分别为80.4%和72.5%,1年生存率分别49.0%和45.1%,2年生存率分别13.7%和11.8%,中位生存期为14.5和13个月,A组略优于B组,但两组疗效在统计学上均无显著性差异(P<0.05)。两组在毒副反应方面静脉炎、脱发等副反应方面有统计学差异(P<0.05)。结论 TP方案和NP方案诱导化疗局部晚期NSCLC均为合理,安全,有效的两种方案,均可作为一线方案推荐临床应用,但TP方案比NP方案在患者耐受性和不良反应方面更好。

关 键 词:非小细胞肺癌(NSCLC)  化疗  比较

Observational study on the induction chemotherapy of TP and NP regimens in unresectable advanced non-small cell lung cancer
Kong Yi.Observational study on the induction chemotherapy of TP and NP regimens in unresectable advanced non-small cell lung cancer[J].Journal of Clinical Pulmonary Medicine,2013,18(2):222-224.
Authors:Kong Yi
Institution:Kong Yi Department of hepatopancreatoblliary of Hunan provincial tumor hospital,Changsha 410013,China
Abstract:Objective To evaluate the efficacy of induction chemotherapy for patients with local advanced non-small cell lung cancer(NSCLC) between TP and NP regimen. Methods collecting 102 advanced non-small-cell lung cancer patients ( Including 26 ca- ses of squamous cell carcinoma, 44 cases of adenocarcinoma and 32 cases of large cell lung cancer)who have received Chemotherapy dur- ing February, 2008 to February, 2010 in our hospital as our study subjects. The patients were randomly divided into two groups, group one ( group A, n = 51 ) was treated with TP chemotherapy and group two ( group B, n = 51 ) was treated with NP chemotherapy. We trying to compare the curative effect, Karuofsky scores,the toxic and adverse effects and the survival condition after one and 2 years between these pairs. Results The total effective rate of the group A and group B was 54.9% and 43. 1%, and the rate of quality of life improvement was 80. 4% and 72.5%. The accumulate survival rate after one year of the group A and group B was 49.0% and 45.1%, accumulate survival rate after two year was 13.7% and 11.8%. Two groups of curative effect had no significant difference in statistically. Complica- tions of two groups, hair loss and phlebitis with significant differences ( P 〈 0. 05 ). Conclusion Both the chemotherapy TP and NP methods are reasonable, safe, effective treatments for locally adanced NSCLC, could be used as first-line schemes for the clinical application, but tolerance and adverse reaction of TP method is better than NP method.
Keywords:Non-small cell lung cancer (NSCLC)  chemotherapy  comparison
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号